Submental Island Flap vs Radial Forearm Free Flap in Tongue Reconstruction (SIPF-RFFF)
Evaluation of Quality of Life Post Tongue Cancer Resection and Reconstruction Using Submental Island Pedicled Flap Versus Radial Forearm Free Flap
調査の概要
状態
詳細な説明
Surgical reconstruction following tongue cancer resection is essential for restoring oral function, speech, swallowing, and facial aesthetics. The Radial Forearm Free Flap (RFFF) is widely considered a gold standard for soft tissue oral reconstruction; however, it requires microvascular expertise and carries donor-site morbidity. The Submental Island Pedicled Flap (SIPF) serves as an alternative, offering a reliable regional pedicled flap with local color match and simplified surgical execution without requiring microvascular anastomoses.
This retrospective observational cohort study aims to compare patients who received SIPF versus RFFF for tongue reconstruction. The primary objective is to evaluate health-related quality of life outcomes using the validated University of Washington Quality of Life Questionnaire version 4 (UW-QOL v4), alongside evaluating postoperative surgical outcomes and donor site morbidity.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Assuit
-
Asyut、Assuit、エジプト
- Faculty of Dental Medicine, Al-Azhar University (Assiut Branch)
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Adult patients (aged 18 years or older) diagnosed with squamous cell carcinoma of the tongue requiring partial or total glossectomy.
- Indication for immediate soft tissue reconstruction using either Submental Island Pedicled Flap (SIPF) or Radial Forearm Free Flap (RFFF).
- Patients eligible and cleared for major surgical resection and flap reconstruction under general anesthesia.
- Patient's informed consent to participate in the study and complete follow-up evaluations.
Exclusion Criteria:
- History of previous radiation therapy or surgical intervention in the head and neck region.
- Clinical or radiological evidence of nodal metastasis in level I submental lymph nodes (for SIPF candidates).
- Severe systemic comorbidities precluding major surgery or prolonged general anesthesia (ASA class IV or higher).
- Distance or inability to commit to the 12-month postoperative follow-up schedule and quality of life assessments.
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
SIPF Group
Patients who underwent tongue reconstruction using Submental Island Pedicled Flap following tongue cancer resection.
|
Surgical reconstruction of tongue defect following oncological resection using a pedicled submental island flap.
|
|
RFFF group
Patients who underwent tongue reconstruction using Radial Forearm Free Flap following tongue cancer resection.
|
Surgical reconstruction of tongue defect following oncological resection using a microvascular radial forearm free flap.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
12-Month Baseline-Adjusted Composite Quality of Life (UW-QOL v4)
時間枠:12 months post operatively
|
Unweighted composite score calculated as the mean of all 12 domains of the University of Washington Quality of Life Questionnaire version 4 (UW-QOL v4), evaluated at 12 months postoperatively and adjusted for baseline composite score using analysis of covariance (ANCOVA).
Scores range from 0 to 100, where higher scores indicate better quality of life.
|
12 months post operatively
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
6-Month Baseline-Adjusted Composite Quality of Life (UW-QOL v4)
時間枠:6 months post operatively
|
Unweighted composite score of the 12 UW-QOL v4 domains evaluated at 6 months postoperatively and adjusted for baseline composite score using ANCOVA.
Scores range from 0 to 100.
|
6 months post operatively
|
|
Operative time
時間枠:Day of surgery (intraoperative)
|
Total duration of surgery measured in hours from initial skin incision to final closure.
|
Day of surgery (intraoperative)
|
|
Length of hospital stay
時間枠:From date of surgery to hospital discharge. Up to 30 days
|
Total duration of inpatient hospital admission measured in days from surgery until discharge.
|
From date of surgery to hospital discharge. Up to 30 days
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Mohamed Serag Attia, MSc、Al-Azhar University
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- AUAREC20240007-3
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。